FFIV vs SYRE · P/E 32, rev $3.09B vs $7.60B cap
F5 Networks Inc (FFIV) versus Spyre Therapeutics Inc. (SYRE) — a side-by-side from cached financials, not a winner call.
F5 Networks Inc (FFIV) is a software - infrastructure company listed on NASDAQ.
Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
Latest reported FFIV revenue for 2025-09-30 was $3.09B. Net income was $692.4M. FFIV currently screens at market cap $21.71B and trailing P/E 31.6.
Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.
FFIV currently screens at market cap $21.71B and trailing P/E 31.6. SYRE currently screens at market cap $7.60B.
Not investment advice. Open the FFIV and SYRE stock pages for the full models.
Not investment advice.